✦ LIBER ✦

PCV49 Economic Evaluation of Rivaroxaban in Stroke Prevention Among Patients With Atrial Fibrillation in Greece

✍ Scribed by G. Kourlaba; N. Maniadakis; G. Andrikopoulos; P. Vardas; A. Llyod; Y. Asukai; T. Evers

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV47 Economic Evaluation of Dabigatran

✍ H.H. Le; P. Pechlivanoglou; P.M. Engelfriet; M.J. Postma; W.K. Redekop 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PCV57 Cost-Effectiveness of Rivaroxaban

✍ A.K. Kapur; I. Chatzitheofilou; L.K. Schang 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCV73 Prevention of Stroke in Patients W

✍ M. Psenkova; M. Lukac; S. Mackovicova; M. Stachova; J. Bielik; G.A. Pietsch; Y. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PCV86 ECONOMIC EVALUATION OF DRONEDARONE

✍ N Maniadakis; V Fragoulakis; K Athanasakis; J Kyriopoulos 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PCV25 RISK OF STROKE AND PREVENTATIVE ST

✍ S Gupta; A Goren; D Freedman 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Prevention of stroke in patients with at

✍ Varughese, Christopher J.; Halperin, Jonathan L. 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 296 KB